Search filters

List of works by Takanori Matsui

Administration of Pigment Epithelium-Derived Factor Inhibits Left Ventricular Remodeling and Improves Cardiac Function in Rats with Acute Myocardial Infarction

scientific article published on February 1, 2011

Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy

scientific article published on March 1, 2011

Anti-inflammatory and atheroprotective properties of glucagon

scientific article published on 01 May 2020

Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)–RAGE-induced proximal tubular cell injury

scientific article published on November 10, 2011

Circulating level of pigment epithelium-derived factor is associated with vascular function and structure: A cross-sectional study

scientific article published on 3 October 2016

Co-treatment with azelinidipine and olmesartan inhibits advanced glycation end products (AGEs) elicited down-regulation of adiponectin mRNA levels in cultured adipocytes partly via its anti-oxidative property

scientific article published on November 20, 2010

Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice

scientific article published on September 30, 2012

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

scientific article published on November 14, 2012

Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A

scientific article published on June 30, 2012

Glucagon-like peptide–1 suppresses advanced glycation end product–induced monocyte chemoattractant protein–1 expression in mesangial cells by reducing advanced glycation end product receptor level

scientific article published on 08 March 2011

Glucose-dependent Insulinotropic Polypeptide (GIP) Inhibits Signaling Pathways of Advanced Glycation End Products (AGEs) in Endothelial Cells via its Antioxidative Properties

scientific article published on May 11, 2012

High White Blood Cell Count and Low Estimated Glomerular Filtration Rate Are Independently Associated With Serum Level of Monocyte Chemoattractant Protein‐1 in a General Population

scientific article published on February 17, 2011

Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)

scientific article published on 16 May 2015

Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells

scientific article published on January 12, 2011

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer

scientific article published on 23 September 2019

Metformin Inhibits Advanced Glycation End Products (AGEs)-induced Growth and VEGF Expression in MCF-7 Breast Cancer Cells by Suppressing AGEs Receptor Expression via AMP-activated Protein Kinase

scientific article published on December 7, 2012

Osteogenic differentiation of mesenchymal stem cells is preserved by partial, but not full peroxisome proliferator-activated receptor-gamma agonist

scientific article published on October 20, 2010

PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation

scientific article published on October 27, 2012

PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression

scientific article published on February 21, 2012

Pigment epithelium-derived factor (PEDF) blocks advanced glycation end products (AGEs)-RAGE-induced suppression of adiponectin mRNA level in adipocytes by inhibiting NADPH oxidase-mediated oxidative stress generation

scientific article published on September 10, 2011

Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties

scientific article published on January 31, 2013

Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes

scientific article published on December 1, 2011

Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography

scientific article published on August 21, 2012

Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level

scientific article published on 03 March 2012

Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function

scientific article published on 21 October 2014

Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes

scientific article published on 02 April 2011

Rosuvastatin Blocks Advanced Glycation End Products-elicited Reduction of Macrophage Cholesterol Efflux by Suppressing NADPH Oxidase Activity via Inhibition of Geranylgeranylation of Rac-1

scientific article published on August 5, 2011

Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects

scientific article published on February 18, 2011

Serum pigment epithelium-derived factor levels are independently associated with decreased number of circulating endothelial progenitor cells in healthy non-smokers

scientific article published on May 17, 2012

Sitagliptin Augments Protective Effects of GLP-1 against Advanced Glycation End Product Receptor Axis in Endothelial Cells

scientific article published on September 19, 2011

The p66shc Gene Expression in Peripheral Blood Monocytes Is Increased in Patients With Coronary Artery Disease

scientific article published on September 1, 2010

Vardenafil, an inhibitor of phosphodiesterase-5, blocks advanced glycation end product (AGE)-induced up-regulation of monocyte chemoattractant protein-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression via elevation of

scientific article published on August 29, 2010

Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product–receptor axis

scientific article published on February 12, 2011

Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats

scientific article published on 06 May 2012